IMCURE THERAPEUTICS

ImCure Therapeutics

#SimilarOrganizations #More

IMCURE THERAPEUTICS

Industry:
Biotechnology

Status:
Active


Similar Organizations

adriacell-logo

Adriacell

Anti-tumor therapeutics

not_available_image

Pathfinder Therapeutics

Pathfinder Therapeutics

senexta-therapeutics-logo

Senexta Therapeutics

Senexta Therapeutics

More informations about "ImCure Therapeutics"

ImCure Therapeutics - Crunchbase Company Profile & Funding

Who are ImCure Therapeutics 's competitors? Alternatives and possible competitors to ImCure Therapeutics may include Diorasis Therapeutics , Pathfinder Therapeutics , and Solaris โ€ฆSee details»

ImCure Therapeutics 2025 Company Profile: Valuation, โ€ฆ

ImCure Therapeutics General Information Description. Developer of cardiovascular and arthritis treatments. The company develops drugs and other water-soluble cholesterol altering compounds for treating cardiovascular and โ€ฆSee details»

Imcure Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...

Explore Imcure Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:184045 (Imcure Therapeutics, Inc.).See details»

Joseph Rubinfeld Ph.D Profile: Contact Information & Network

May 30, 1997 Dr. Joseph Rubinfeld is the Founder of ImCure Therapeutics. He served as Independent Director at International Infusion. He is the Founder of JJ Pharma. He served as โ€ฆSee details»

Imcure Therapeutics, Inc.:Company Profile & Technical Research ...

Oct 27, 2022 Imcure Therapeutics Inc is headquartered in US CA. Imcure Therapeutics Inc was founded in 2003. Imcure Therapeutics Inc has a total of 15 patents . Related Topics. โ€ฆSee details»

184045 (Imcure Therapeutics, Inc.) - Drug Targets, Indications, โ€ฆ

100 Translational Medicine associated with 184045 (Imcure Therapeutics, Inc.) Login to view more data 100 Patents (Medical) associated with 184045 (Imcure Therapeutics, Inc.)See details»

IMCURE THERAPEUTICS, INC. :: California (US) - OpenCorporates

IMCURE THERAPEUTICS, INC. Company Number 2569549 Previous Company Numbers. C2569549; Status Suspended Ftb/Sos Incorporation Date 18 December 2003 (about 19 years โ€ฆSee details»

Imcure Therapeutics, Inc. in San Francisco CA - Company Profile

Imcure Therapeutics, Inc. Overview. Imcure Therapeutics, Inc. filed as an Articles of Incorporation in the State of California and is no longer active.This corporate entity was filed approximately โ€ฆSee details»

Imcure Therapeutics, Inc.:Patent,Patent Application,Portfolio โ€ฆ

Discovery Company profile page for Imcure Therapeutics, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

ImCure Therapeutics (ImCure Therapeutics) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ โ€ฆ

ไบ†่งฃImCure Therapeutics (ImCure Therapeutics)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„ใ€‚See details»

InnoCure Therapeutics 2025 Company Profile: โ€ฆ

InnoCure Therapeutics General Information Description. Developer of biopharmaceuticals dedicated to the discovery and development of novel drugs. The company's next-generation protein degradation mechanisms are โ€ฆSee details»

GeneSegues Therapeutics - Crunchbase Company Profile & Funding

Alternatives and possible competitors to GeneSegues Therapeutics may include Diorasis Therapeutics, Genex Space, and ImCure Therapeutics. Browse By: Organizations, People, โ€ฆSee details»

Emcure Pharmaceuticals - Crunchbase Company Profile & Funding

Emcure was born out of the vision to create a healthcare company that would address the vast healthcare needs. They commitment and drive have propelled our growth from a single โ€ฆSee details»

Orgenesis and Cure Therapeutics Form Joint Venture for Cell

On Dec. 9, 2020, Orgenesis, a global biotech company focused on cell and gene therapies, and Cure Therapeutics, a developer of immuno-oncology and cell and gene therapies, announced โ€ฆSee details»

Imfinzi approved in the US as first and only perioperative ...

Mar 31, 2025 Notes. Muscle-invasive bladder cancer Bladder cancer is the 9th most common cancer in the world, with more than 614,000 patients diagnosed each year. 5 The most โ€ฆSee details»

Development of an Innovative Treatment for Parkinson's

23 hours ago /CNW/ - Sylvain Chrétien, CEO and cofounder of Canadian biotech firm Synucure Therapeutics, ... Organization Profile. Synucure Therapeutics Inc. Contact Cision. 866-245-2317See details»

Emcure Pharmaceuticals: Founder | IPO | Subsidiaries - StartupTalky

Jul 12, 2024 Emcure's pipeline of innovative pharmaceuticals and unique biologics portfolio support the company's innovative business model. The organization hopes to maintain its โ€ฆSee details»

DeepCure

DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure โ€ฆSee details»

Emcure Pharmaceuticals | Leading Global Pharmaceutical Company

Aug 5, 2021 Emcure Pharmaceuticals Limited was built with the purpose and core belief of making E ffective M edicines to Cure patients enabling them to lead healthier lives. We are a โ€ฆSee details»

Emcure Pharma IPO: All you need to know - Value Research

Jul 2, 2024 It is the market leader in the gynaecology and HIV antiviral therapeutics, and is among the top 10 players in five other therapeutic areas in terms of market share. Vertical โ€ฆSee details»

linkstock.net © 2022. All rights reserved